| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/25/2012 | CN101564482B Compound liniment for treating acne rosacea |
| 01/25/2012 | CN101553208B A pharmaceutically stable suspension of megestrol material |
| 01/25/2012 | CN101549002B Tincture for curing flat wart and method for preparing the same |
| 01/25/2012 | CN101534821B Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 01/25/2012 | CN101485848B Decoction for treating eczema and preparation method thereof |
| 01/25/2012 | CN101461803B Use of grape inner ester |
| 01/25/2012 | CN101450209B Preparation method of transdermal immune influenza multivalent vaccine |
| 01/25/2012 | CN101450193B Traditional Chinese medicine granules for increasing eggs |
| 01/25/2012 | CN101380414B Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof |
| 01/25/2012 | CN101361774B Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof |
| 01/25/2012 | CN101360484B Machine and method for pharmaceutical and pharmaceutical-like product assembly |
| 01/25/2012 | CN101353279B Medicine for injury, preparation thereof and preparation of woundplaster of the medicine for injury |
| 01/25/2012 | CN101332268B Medicine for treating rhinitis, sinusitis |
| 01/25/2012 | CN101316865B Method for preparing biological degradable membrane from semi-refined kappa carrageen glycan |
| 01/25/2012 | CN101301467B Uses of BMP-7 in preparing medicament for preventing and/or treating liver fibrosis |
| 01/25/2012 | CN101301357B Use of schisandra chinensis extract in anti-depression medicament |
| 01/25/2012 | CN101269067B Antibacterial gynecology externally used pharmaceutical combination |
| 01/25/2012 | CN101269049B Phosphoric acid ligustrazine micropore permeation pump control-release tablet and preparation method thereof |
| 01/25/2012 | CN101244158B Chinese medicinal herb for effectively treating cirrhosis, liver ascites |
| 01/25/2012 | CN101244126B Composition for treating eye disease and preparation method |
| 01/25/2012 | CN101244122B Pharmaceutical combination |
| 01/25/2012 | CN101152264B Medicament for treating prostate disease and urinary tract infection and method for preparing the same |
| 01/25/2012 | CN101143135B Melatonin orally disintegrating tablet and preparation method thereof |
| 01/24/2012 | USRE43134 Biocompatible denatured albumin lamina |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101718 Methods of administering porcine B-domainless fVIII |
| 01/24/2012 | US8101664 Propellants; aerosols; skin disorders |
| 01/24/2012 | US8101630 Extended release opioid abuse deterrent compositions and methods of making same |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101575 Glycopeptide phosphonate derivatives |
| 01/24/2012 | US8101212 Bioactive botanical cosmetic compositions and processes for their production |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101208 Sensate compositions and delivery systems therefor |
| 01/24/2012 | US8101207 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 01/24/2012 | US8101206 Method of attenuating swelling or inflammation |
| 01/24/2012 | US8101205 Controlled release composition |
| 01/24/2012 | US8101204 Hard capsule composition and method of use |
| 01/24/2012 | US8101203 Hard capsule composition and method of use |
| 01/24/2012 | US8101200 Drug delivery; insertion at tumor site |
| 01/24/2012 | US8101163 Transdermal compositions |
| 01/24/2012 | US8101160 Formulations for use in inhaler devices |
| 01/24/2012 | US8101114 Particle based molding |
| 01/24/2012 | US8100890 Special purpose fluid dispenser with pre-filled reservoir |
| 01/24/2012 | US8100889 Body-insertable apparatus |
| 01/24/2012 | US8100888 Capsulated medical equipment |
| 01/24/2012 | CA2661099C Pharmaceutical compositions comprising cefquinome |
| 01/24/2012 | CA2594718C Gnrh analogue formulations |
| 01/24/2012 | CA2592102C Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same |
| 01/24/2012 | CA2534372C Foam carrier containing amphiphilic copolymeric gelling agent |
| 01/24/2012 | CA2527499C Foamable pharmaceutical compositions and methods for treating a disorder |
| 01/24/2012 | CA2515426C Uses and formulations for transdermal or transmucosal application of active agents |
| 01/24/2012 | CA2513532C Pearlescent film coating systems and substrates coated therewith |
| 01/24/2012 | CA2496249C 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 01/24/2012 | CA2494761C Oral pharmaceutical compositions comprising cyclosporin |
| 01/24/2012 | CA2492709C Process for the preparation of crystalline nano-particle dispersions |
| 01/24/2012 | CA2483827C Pharmaceutical formulations with improved bioavailability |
| 01/24/2012 | CA2478825C Composition having gelling properties for the prolonged delivery of bioactive substances |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2461647C Lysin-deficient bacteriophages having reduced immunogenicity |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2324901C Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/24/2012 | CA2269078C Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/24/2012 | CA2221730C Use of angiotensin ii type 2 receptor agonists in tissue repair |
| 01/19/2012 | WO2012009723A1 C-met modulator pharmaceutical compositions |
| 01/19/2012 | WO2012009722A1 C-met modulator pharmaceutical compositions |
| 01/19/2012 | WO2012009684A2 Drug delivery medical device |
| 01/19/2012 | WO2012009503A1 Palatable pharmaceutical composition comprising vx-950 |
| 01/19/2012 | WO2012009474A1 Method and formulations for treating sialic acid deficiencies |
| 01/19/2012 | WO2012009438A2 Anti-appetite adhesive compositions |
| 01/19/2012 | WO2012009406A2 Gold particles and methods of making and using the same in cancer treatment |
| 01/19/2012 | WO2012009405A2 Skin care compositions |
| 01/19/2012 | WO2012009144A2 A bioactive dose containing a material for modulating ph of a bodily fluid |
| 01/19/2012 | WO2012009080A2 Device for radiation-activated localized delivery of treatment agents |
| 01/19/2012 | WO2012009048A1 Dual drug delivery using silicone gels |
| 01/19/2012 | WO2012008869A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 01/19/2012 | WO2012008845A1 Parenteral formulations of elacytarabine derivatives |
| 01/19/2012 | WO2012008834A1 Microparticles comprising a small heat-shock protein |
| 01/19/2012 | WO2012008779A2 A liquid formulation of long-acting human growth hormone conjugate |
| 01/19/2012 | WO2012008718A2 Patch for treating and alleviating symptoms of skin diseases accompanied by effusion of blood proteins |
| 01/19/2012 | WO2012008675A1 Sustained-release tablet containing trimebutine |
| 01/19/2012 | WO2012008396A1 Patch support for water-based plaster |
| 01/19/2012 | WO2012008395A1 Substrate of three-layer structure and water-containing adhesive patch including same |
| 01/19/2012 | WO2012008271A1 Oil-based gel-like composition |
| 01/19/2012 | WO2012008159A1 Solid dispersion of alfa-ketoamide derivatives |
| 01/19/2012 | WO2012007913A2 Oral administration forms for controlled release of rifampicin for the treatment of bacterial infections and inflammatory diseases of the gastrointestinal tract |
| 01/19/2012 | WO2012007906A2 Eudermic compositions |
| 01/19/2012 | WO2012007886A1 Lipid bilayer carrier for drugs or imaging agents |
| 01/19/2012 | WO2012007758A2 Pharmaceutical formulations |
| 01/19/2012 | WO2012007711A1 Formulation comprising a type b lantibiotic |
| 01/19/2012 | WO2012007672A1 Pharmaceutical form for combating chemical submission of a medicament |
| 01/19/2012 | WO2012007584A2 Composition for the treatment of superficial lesions |
| 01/19/2012 | WO2012007570A2 New formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | WO2012007538A1 Ferrimannitol-ovalbumin tablet composition |
| 01/19/2012 | WO2012007517A1 Formulations of 14 - epi -analogues of vitamin d |
| 01/19/2012 | WO2012007512A1 New formulations of 14 - epi -analogues of vitamin d |
| 01/19/2012 | WO2012007352A1 Aqueous composition comprising bromhexine |
| 01/19/2012 | WO2012007159A2 Novel gastro-retentive dosage forms |
| 01/19/2012 | WO2012007150A1 Transdermal therapeutic system with a choline esterase inhibitor |
| 01/19/2012 | WO2012007130A1 Treatment of lung infections by administration of tobramycin by aerolisation |
| 01/19/2012 | WO2012006967A1 Poly(ethylene oxide) and base surfactant in suppository composition |